/
/
/

Valiant Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
₹115 Cr₹92 Cr₹52 Cr₹46 Cr₹47 Cr₹58 Cr₹35 Cr₹21 Cr₹19 Cr₹31 Cr₹41 Cr₹60 Cr₹51 Cr₹90 Cr₹71 Cr₹88 Cr
₹86 L₹17 L₹63 L₹87 L₹66 L-₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹78 L₹1 Cr
₹116 Cr₹92 Cr₹53 Cr₹47 Cr₹47 Cr₹55 Cr₹37 Cr₹25 Cr₹22 Cr₹33 Cr₹42 Cr₹63 Cr₹54 Cr₹92 Cr₹72 Cr₹89 Cr
₹89 Cr₹90 Cr₹55 Cr₹47 Cr₹45 Cr₹54 Cr₹35 Cr₹29 Cr₹22 Cr₹36 Cr₹47 Cr₹61 Cr₹48 Cr₹82 Cr₹61 Cr₹78 Cr
₹30 Cr₹5 Cr-₹26 L₹95 L₹3 Cr₹2 Cr₹2 Cr-₹3 Cr₹43 L-₹2 Cr-₹5 Cr₹2 Cr₹6 Cr₹10 Cr₹11 Cr₹12 Cr
₹1 Cr₹1 Cr₹68 L₹14 L₹7 L₹6 L₹6 L₹60,000₹5 L₹2 L₹2 L₹2 L₹2 L₹3 L₹4 L₹17 L
₹26 Cr₹1 Cr-₹3 Cr₹28 L₹2 Cr₹94 L₹2 Cr-₹4 Cr-₹16 L-₹3 Cr-₹5 Cr₹1 Cr₹6 Cr₹10 Cr₹10 Cr₹12 Cr
₹21 Cr₹2 Cr-₹7 Cr₹20 L₹2 Cr₹70 L₹2 Cr-₹5 Cr-₹51 L-₹1 Cr-₹4 Cr₹79 L₹4 Cr₹8 Cr₹8 Cr₹9 Cr

Share Price Live Stats

Open (₹)105.97
Volume (₹)71,202.00
High (₹)105.97
Upper Circuit105.97
Low (₹)105.00
Lower Circuit95.89
Prev Close100.93
52W High (₹)110.70
Price105.97
52W Low (₹)49.51

Share Market Cap & Key Ratios Overview

M.Cap (₹)554.91 Cr
Div. Yield (%)0.00
PE Ratio34.67
Debt to Equity0.52
Price to Book1.42
Book Value50.05
EPS (TTM)2.95
Face Value10.00
ROE (%)-0.93

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
VALIANTLAB-BENSE
LTP
1W Low
1W High
Market cap (₹)
1899-21 (-1.09%)
1895
1984.80
4,56,833Cr
9100-139 (-1.50%)
9087
9467
2,45,426Cr
4857-193 (-3.82%)
4823
5066
1,87,320Cr
1120-71 (-5.96%)
1120
1187
1,13,217Cr
1385-38.5 (-2.70%)
1375.50
1426.10
1,12,212Cr
1840-98.5 (-5.08%)
1811.70
1949
1,01,155Cr
2110-61.5 (-2.83%)
2100.60
2192
97,626Cr
2327.9-55 (-2.31%)
2317
2419.20
96,859Cr
1151-27 (-2.29%)
1151
1179.90
96,406Cr
1653.1+7.8 (0.47%)
1622.60
1717
93,614Cr
105.97+6.32 (6.34%)
91.53
105.97
555Cr

Key Highlights of Valiant Laboratories Ltd’s P&L

In 2025-03-31, Valiant Laboratories Ltd reported total revenue of ₹138.83Cr, compared with ₹191.74Cr in 2024-03-31, reflecting Valiant Laboratories Ltd turnover.

Depreciation was ₹2.09Cr and finance costs were ₹17.53Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹-₹1.51Cr in 2025-03-31 as compared to ₹-₹76.95Lakh in 2024-03-31.

Net Profit (PAT) was ₹-₹2.2Cr in 2025-03-31 compared with ₹31.96Lakh in 2024-03-31.

Earnings per share (EPS) were ₹-0.51 in 2025-03-31, compared with ₹0.07 in 2024-03-31.